210 likes | 418 Views
Program Goals. ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy. DPP-4 Inhibitors: Benefits and Risks. DPP-4 Inhibitors: Large-Scale CV Safety Studies. DPP-4 Inhibitor CV Safety Study: SAVOR-TIMI 53. DPP-4 Inhibitor CV Safety Study: EXAMINE. SGLT-2 Inhibitors: Benefits.
E N D